Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Identification of a potent agonist of the orphan nuclear receptor Nurr1.

× No keyword cloud information.

23 in total

1. Structure-dependent activation of NR4A2 (Nurr1) by 1,1-bis(3'-indolyl)-1-(aromatic)methane analogs in pancreatic cancer cells.

Authors: Xi Li; Syng-Ook Lee; Stephen Safe
Journal: Biochem Pharmacol Date: 2012-03-03 Impact factor: 5.858

Review 2. The role of histone acetylation in memory formation and cognitive impairments.

Authors: Lucia Peixoto; Ted Abel
Journal: Neuropsychopharmacology Date: 2012-06-06 Impact factor: 7.853

3. Nurr1 and PPARγ protect PC12 cells against MPP(+) toxicity: involvement of selective genes, anti-inflammatory, ROS generation, and antimitochondrial impairment.

Authors: Mohammad Jodeiri Farshbaf; Mahboobeh Forouzanfar; Kamran Ghaedi; Abbas Kiani-Esfahani; Maryam Peymani; Alireza Shoaraye Nejati; Tayebeh Izadi; Khadijeh Karbalaie; Maryam Noorbakhshnia; Soheila Rahgozar; Hossein Baharvand; Mohammad Hossein Nasr-Esfahani
Journal: Mol Cell Biochem Date: 2016-07-19 Impact factor: 3.396

4. The nuclear receptor, Nor-1, markedly increases type II oxidative muscle fibers and resistance to fatigue.

Authors: Michael A Pearen; Natalie A Eriksson; Rebecca L Fitzsimmons; Joel M Goode; Nick Martel; Sofianos Andrikopoulos; George E O Muscat
Journal: Mol Endocrinol Date: 2012-01-26

Review 5. Orphan nuclear receptors in drug discovery.

Authors: Yanhong Shi
Journal: Drug Discov Today Date: 2007-04-26 Impact factor: 7.851

6. The NR4A orphan nuclear receptors mediate transcription-dependent hippocampal synaptic plasticity.

Authors: Morgan S Bridi; Ted Abel
Journal: Neurobiol Learn Mem Date: 2013-07-05 Impact factor: 2.877

Review 7. Structure-dependent activation of gene expression by bis-indole and quinoline-derived activators of nuclear receptor 4A2.

Authors: Xi Li; Ronald B Tjalkens; Rupesh Shrestha; Stephen Safe
Journal: Chem Biol Drug Des Date: 2019-07-21 Impact factor: 2.817

Review 8. NURR1 in Parkinson disease--from pathogenesis to therapeutic potential.

Authors: Mickael Decressac; Nikolaos Volakakis; Anders Björklund; Thomas Perlmann
Journal: Nat Rev Neurol Date: 2013-10-15 Impact factor: 42.937

9. Low dose bexarotene treatment rescues dopamine neurons and restores behavioral function in models of Parkinson's disease.

Authors: Krista McFarland; Tracy A Spalding; David Hubbard; Jian-Nong Ma; Roger Olsson; Ethan S Burstein
Journal: ACS Chem Neurosci Date: 2013-10-11 Impact factor: 4.418

Review 10. Minireview: role of orphan nuclear receptors in cancer and potential as drug targets.

Authors: Stephen Safe; Un-Ho Jin; Erik Hedrick; Alexandra Reeder; Syng-Ook Lee
Journal: Mol Endocrinol Date: 2013-12-02